Krónikus vesebetegség: vizsgálatok itt: Japán

In Japán 13 Also abroad 798

13 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

No phaseTaking people
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
Where
Many Locations
Életkor
18 év and over
People
50 000 worldwide
Run by
Bayer
See details and how to joinNCT06278207
3. fázisTaking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Aira, Amagasaki-shi, Beppu-shi, Chigasaki-shi, Fujinomiya-shi, Hakodate-shi, Hamamatsu, Higashihiroshima-shi, Iizuka-shi, Inashiki-gun, Iwata-shi, Kagoshima, Kamakura-shi, Kanazawa, Kashiwara-shi, Kasugai-shi, Kita-ku, Kitakyushu, Kitakyushu-shi, Kobe, Kumagaya-shi, Kurashiki-shi, Kuse-gun, Kuwana-shi, Kyoto, Matsusaka-shi, Matsuyama, Meguro-ku, Minatoku, Minokamo Shi, Miyakonojo-shi, Morioka, Nagaoka-shi, Naka, Narita-shi, Obihiro-shi, Ōita, Ōme, Ōmihachiman, Osaka, Saga, Sapporo, Sendai, Shibuya-ku, tabashi City, Tanabe-shi, Toyoake-shi, Toyohashi, Tsu, Yaizu-shi, Yokohama, Yoshida-gun
Életkor
18 év and over
People
5000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
3. fázisTaking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Chūōku, Hamadayama, Suginami-ku, Izumisano, Kobe, Kofu, Kumamoto, Shinjuku-ku, Takarazuka, Uji, Wakayama
Életkor
50 év and over
People
7140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
No phaseCsak meghívásos
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Where
Kanagawa, Okinawa
Életkor
0 Minutes to 2 hét
People
8000 worldwide
Run by
Indiana University
See details and how to joinNCT06823115
2. fázisTaking people
Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
Where
Kamakura, Kasugai, Matsubara, Matsudo
Életkor
18 év to 80 év
People
180 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07830719 · EU 2026-525974-21-00
3. fázisTaking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Chiba, Kasugai, Kawasaki, Kyoto, Matsumoto, Niigata, Okayama, Ōmihachiman, Osaka, Sapporo, Sendai, Toyoake, Toyota, Yokohama
Életkor
18 év to 100 év
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
3. fázisTaking people
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Where
Ageo, Asahi-shi, Chiba, Fukaya, Fukui-shi, Izumisano, Izunokuni-shi, Kariya, Kisarazu-shi, Kita-ku, Kitakyusyu-shi, Kofu, Koga-shi, Komatsu-shi, Koshigaya-shi, Kumagaya-shi, Kumamoto, Kurashiki-shi, Kuwana-shi, Kyoto, Matsumoto-shi, Minamiuonuma, Minatoku, Minokamo Shi, Morioka, Nagoya, Naka, Nerima-ku, Osaka, Sendai, Takatsuki-shi, Toride-shi, Tsu, Urayasu, Yokohama
Életkor
18 év to 99 év
People
2800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00
2/3. fázisTaking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Hashima-gun, Higashiosaka-shi, Hiroshima, Hokkaido, Ibaraki, Ichinomiya-shi, Inashiki-gun, Kagoshima, Kamakura-shi, Kanazawa, Kitakyushu-shi, Kurume, Kurume-shi, Kusatsu-shi, Kyoto, Maebashi, Matsubara-shi, Nagaoka-Shi, Nagoya, Ogaki-Shi, Ōmihachiman, Oyama-shi, Sakaimachi, Sapporo, Shinjuku-Ku, Takasaki-Shi, Tsukuba, Ube-shi, Urayasu-shi, Yamagata, Yokohama, Yonago-shi
Életkor
18 év and over
People
3110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
3. fázisTaking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Aira, Akita, Asahikawa-shi, Chūōku, Fujisawa-shi, Fukuoka, Hachioji-shi, Hamamatsu, Hiroshima, Ichikawa-shi, Ina-shi, Iruma-Gun, Izunokuni-shi, Kamakura-shi, Kamiina-gun, Kanazawa, Kasugai-shi, Kasuga-shi, Kawachinagano-shi, Kitakyushu, Kitakyushu-shi, Kumamoto, Kurume, Kuwana-shi, Matsumoto-shi, Minatoku, Minokamo Shi, Moriyama-shi, Nagoya, Naka, Ōita, Okayama, Osaka, Oyama-shi, Sakaishi, Sakushu, Sapporo, Sasebo-shi, Shinjuku-ku, Suita-shi, Suwa-shi, Takasago-shi, Tsu, Ueda-shi, Ushiku-shi, Utsunomiya, Yokohama
Életkor
18 év and over
People
7000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
3. fázisTaking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Where
Chigasaki-shi, Chikushino-shi, Gifu, Kagoshima, Kitakyushu, Kumamoto, Kyoto, Maebashi, Nagoya, Osaka, Sapporo, Suita-shi, Tachikawa-shi, Toyota-Shi
Életkor
18 év and over
People
900 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00
1. fázisTaking people
A Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus
Where
Fukuoka
Életkor
18 év to 64 év
People
120
Run by
Ono Pharmaceutical Co., Ltd.
See details and how to joinNCT07619157
2. fázisTaking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
Aichi, Ibaraki, Kanagawa, Kita-ku, Tokyo, Koriyama-shi, Fukushima, Saitama, Sendai-shi, Miyagi, Siga, Tokyo
Életkor
18 év and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00
No phaseTaking people
Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
Where
Sakai
Életkor
20 év and over
People
2000
Run by
Osaka Metropolitan University
See details and how to joinNCT06694012